Michael Yehuda Mashaal
Founder chez HealthCor Partners Management LP
Profil
Michael Y.
Mashaal, M.D., Senior Managing Director, also a Founding Partner of HealthCor Partners, joined HealthCor Group in September 2005.
Prior to joining the private equity team in 2007, Dr. Mashaal was a Senior Research Analyst focused on biotechnology for the HealthCor Group from 2005 to 2007.
Previously, from 2000 to 2005, Dr. Mashaal served as a Research Analyst focused on healthcare and biotechnology for several large institutional investment firms.
Dr. Mashaal graduated from Emory University in 1994 with a B.A.
in Biology.
After receiving an M.D.
at State University of New York at Stony Brook School of Medicine in 1998, Dr. Mashaal trained in general surgery at the University Hospital at Stony Brook from 1998 to 1999.
Dr. Mashaal currently serves on the board of directors of KellBenx and Orphion Therapeutics.
He also serves as a board observer of HeartFlow and Paige.AI.
Previously, Dr. Mashaal served on the board of directors of Corindus Vascular Robotics (acquired by Siemens Healthineers), Paradigm Spine (acquired by RTI Surgical), Apatech (acquired by Baxter), Velcera (acquired by Perrigo) and ReShape LifeSciences.
He also served as a board observer of Natera, in addition to service on other private company boards.
Postes actifs de Michael Yehuda Mashaal
| Sociétés | Poste | Début |
|---|---|---|
HealthCor Partners Management LP
 HealthCor Partners Management LP Investment ManagersFinance HealthCor Partners Management LP (HealthCor Partners) is a private equity subsidiary of HealthCor Group LLC founded in 2007 by Michael Yehuda Mashaal, Arthur Bruce Cohen and Joseph Patrick Healey. The firm is headquartered in New York. | Founder | 01/09/2005 |
HealthCor Partners Fund LP
 HealthCor Partners Fund LP Investment ManagersFinance HealthCor Partners Fund LP invests in companies located in the US. The fund targets the companies operating in the fields of healthcare and life sciences. The fund provides financing in the form of equity and debt for restructurings, recapitalizations, later stage requirements, buyouts , acquisitions and other special situations with an investment size ranges between $5 million to $25 million in each portfolio company . The fund makes minority and/or control investments. The fund also invests in public companies. | Director/Board Member | - |
| HealthCor Hybrid Offshore Ltd. | Director/Board Member | - |
HealthCor Partners Fund II LP
 HealthCor Partners Fund II LP Investment ManagersFinance HealthCor Partners Fund II LP invests primarily in later-stage developmental and growing (private or publicly traded) mid-sized companies across all sectors of the healthcare and life sciences industry. The fund makes minority and controlling investments. It backs experienced management teams in leveraged buyouts and in creating growing companies through a series of acquisitions. It also selectively invests in restructurings, recapitalizations and other special situations involving more established healthcare companies. It makes equity and equity related investments between USD 5 - 25 million in each portfolio company. | Director/Board Member | - |
ReShape Medical, Inc.
 ReShape Medical, Inc. Medical SpecialtiesHealth Technology ReShape Medical, Inc. develops non-surgical medical devices for the treatment of obesity. The company is headquartered in San Mateo, CA. | Director/Board Member | - |
Orphion Therapeutics, Inc.
 Orphion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orphion Therapeutics, Inc. develops novel gene therapies for the treatment of genetic disorders. The private company is based in Great Neck, NY. The company was founded by Samuel I. Backenroth. The CEO is Jason Scott Slakter. | Director/Board Member | - |
Anciens postes connus de Michael Yehuda Mashaal
| Sociétés | Poste | Fin |
|---|---|---|
ReShape Weightloss, Inc.
 ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology ReShape Weightloss, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded in December 2002 and is headquartered in San Clemente, CA. | Director/Board Member | 08/06/2018 |
| CORINDUS VASCULAR ROBOTICS INC | Director/Board Member | 27/02/2017 |
Corindus, Inc.
 Corindus, Inc. Medical SpecialtiesHealth Technology Corindus, Inc. designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s initial product, the CorPath system, provides procedure control from an interventional cockpit, allowing for precise, robotic-assisted placement of coronary guidewires and stent/balloon catheters. | Director/Board Member | 12/08/2014 |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Michael Yehuda Mashaal
| Emory University | Undergraduate Degree |
| Stony Brook University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
S.A.C. Capital Advisors LP
 S.A.C. Capital Advisors LP Investment ManagersFinance Founded by Steven A. Cohen in 1992, S.A.C. Capital Advisors LP is a hedge fund manager located in Stamford, Connecticut with offices in New York City, Chicago and Boston. | Finance |
| Paramount Capital, Inc. | |
| HealthCor Hybrid Offshore Ltd. | Miscellaneous |
HealthCor Partners Fund LP
HealthCor Partners Fund LP Investment ManagersFinance HealthCor Partners Fund LP invests in companies located in the US. The fund targets the companies operating in the fields of healthcare and life sciences. The fund provides financing in the form of equity and debt for restructurings, recapitalizations, later stage requirements, buyouts , acquisitions and other special situations with an investment size ranges between $5 million to $25 million in each portfolio company . The fund makes minority and/or control investments. The fund also invests in public companies. | Finance |
ReShape Medical, Inc.
ReShape Medical, Inc. Medical SpecialtiesHealth Technology ReShape Medical, Inc. develops non-surgical medical devices for the treatment of obesity. The company is headquartered in San Mateo, CA. | Health Technology |
HealthCor Group LLC
 HealthCor Group LLC Investment ManagersFinance HealthCor Group LLC provides investment advisory services to private investment funds. The company is headquartered in New York, NY. | Finance |
Your Internet Defender, Inc.
 Your Internet Defender, Inc. Medical SpecialtiesHealth Technology Your Internet Defender, Inc. operates as a holding company with interests in vascular robotic assisted systems. The company through its subsidiary designs, manufactures and sell CorPath precision vascular robotic-assisted systems for use in interventional vascular procedures. Its flagship product, the CorPath Vascular Robotics System, brings the vascular robotic system to facilitate stent placement for percutaneous coronary intervention procedures performed in an interventional cath lab in which the physician uses a control panel console located within an interventional cockpit to measure, manipulate, and advance devices with robotic precision. The company was founded on May 4, 2011 and is headquartered in Waltham, MA. | Health Technology |
HealthCor Partners Fund II LP
HealthCor Partners Fund II LP Investment ManagersFinance HealthCor Partners Fund II LP invests primarily in later-stage developmental and growing (private or publicly traded) mid-sized companies across all sectors of the healthcare and life sciences industry. The fund makes minority and controlling investments. It backs experienced management teams in leveraged buyouts and in creating growing companies through a series of acquisitions. It also selectively invests in restructurings, recapitalizations and other special situations involving more established healthcare companies. It makes equity and equity related investments between USD 5 - 25 million in each portfolio company. | Finance |
ApaTech Ltd.
 ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Health Technology |
EnteroMedics, Inc.
 EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Health Technology |
Corindus, Inc.
Corindus, Inc. Medical SpecialtiesHealth Technology Corindus, Inc. designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s initial product, the CorPath system, provides procedure control from an interventional cockpit, allowing for precise, robotic-assisted placement of coronary guidewires and stent/balloon catheters. | Health Technology |
Velcera LLC
 Velcera LLC Pharmaceuticals: MajorHealth Technology Velcera LLC operates as a pharmaceutical company. It focuses on innovation in the expanding pet health market and its product development targets pet medicines in pain management, anti-allergy and parasiticides that can provide superior convenience and greater compliance than traditional products. The firm is developing Promist, a transmucosal oral mist drug delivery technology for use in companion animals. It is also developing Promist products, including VEL504 for pain management and VEL502 for treating allergic atopic dermatitis in canines. The company was founded ion February 18, 2010 and is headquartered in Yardley, PA. | Health Technology |
HealthCor Partners Management LP
HealthCor Partners Management LP Investment ManagersFinance HealthCor Partners Management LP (HealthCor Partners) is a private equity subsidiary of HealthCor Group LLC founded in 2007 by Michael Yehuda Mashaal, Arthur Bruce Cohen and Joseph Patrick Healey. The firm is headquartered in New York. | Finance |
Corindus Vascular Robotics, Inc.
 Corindus Vascular Robotics, Inc. Medical SpecialtiesHealth Technology Corindus Vascular Robotics, Inc. engages in the provision of robotic-assisted vascular interventions. It provides CorPath platform for medical procedures. The company was founded by Tal Wenderow in 2002 and is headquartered in Waltham, MA. | Health Technology |
ReShape Weightloss, Inc.
ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology ReShape Weightloss, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded in December 2002 and is headquartered in San Clemente, CA. | Health Technology |
Orphion Therapeutics, Inc.
Orphion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orphion Therapeutics, Inc. develops novel gene therapies for the treatment of genetic disorders. The private company is based in Great Neck, NY. The company was founded by Samuel I. Backenroth. The CEO is Jason Scott Slakter. | Health Technology |
